Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Jonathan Thomas, Ph D, Jd Appointed As President and CEO of California Institute for Regenerative Medicine (Cirm)

PRIVATEJul 10, 2024almost 2 years ago

Position

Chief Executive Officer

Company

California Institute for Regenerative Medicine (CIRM)

Jonathan Thomas
San FranciscoBiotechnologyHealth Care

Description

The Independent Citizens’ Oversight Committee (ICOC) announces the appointment of Jonathan Thomas, PhD, JD as the new President and CEO of the California Institute for Regenerative Medicine (CIRM). Dr Thomas, also known as JT, previously served as the ICOC Board Chair and most recently as CIRM’s Interim CEO. His appointment comes after a thorough presidential search process following the departure of Dr

Company Information

Company

California Institute for Regenerative Medicine (CIRM)

Location

San Francisco, California, United States

About

The California Institute for Regenerative Medicine (CIRM) was created to accelerate stem cell treatments to patients with unmet medical needs, with a focus on partnering with academia and industry to fast track the development of promising stem cell technologies.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for California Institute for Regenerative Medicine (CIRM)'s next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.